Cargando…
Bone morphogenetic protein type IB receptor is progressively expressed in malignant glioma tumours.
The distribution of bone morphogenetic protein (BMP) type I receptors and the activin type I receptor (ActR-I) was investigated in 16 cases of human glioma and five cases of non-tumourous gliosis tissue by immunohistochemical technique. Both BMP type IA (BMPR-IA) and the type IB (BMPR-IB) receptors...
Autores principales: | Yamada, N., Kato, M., ten Dijke, P., Yamashita, H., Sampath, T. K., Heldin, C. H., Miyazono, K., Funa, K. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074358/ https://www.ncbi.nlm.nih.gov/pubmed/8605097 |
Ejemplares similares
-
A rapid and sensitive bioassay to measure bone morphogenetic protein activity
por: Zilberberg, Lior, et al.
Publicado: (2007) -
Therapeutic Potential for Bone Morphogenetic Protein 4 in Human Malignant Glioma
por: Xi, Guifa, et al.
Publicado: (2017) -
Bone morphogenetic protein receptor signal transduction in human disease
por: Gomez‐Puerto, Maria Catalina, et al.
Publicado: (2018) -
Overactive bone morphogenetic protein signaling in heterotopic ossification and Duchenne muscular dystrophy
por: Shi, SongTing, et al.
Publicado: (2012) -
Cercosporamide inhibits bone morphogenetic protein receptor type I kinase activity in zebrafish
por: Hoeksma, Jelmer, et al.
Publicado: (2020)